quarter. Summary of Financial Performance Analysis of the Operating Results Revenues For the third quarter of 2019, the three-month period ended September 30, 2019, the Company generated revenues of 485
, Aurum and Aurum Company Limited (together with the Company, the “Group”) which engages in distribution of bakery products and equipment. Analysis of Financial Performance Revenues Business categories
Company Limited (the “Company”) Board of Meeting No.1/2018 on 22 February 2018, the resolution to certify the Company’s financial statements and performance for the yearly ending 31 December 2017 which has
subsidiaries collectively, as the case may be. The size of the transaction is equal to 12.52 percent which is calculated by the financial statement as of June 30, 2019. When calculate the Acquisition of Asset is
") would like to describe and analyze the financial position and operating results for quarter 1-2018 are summarized as follows. Performance Analysis For the Quarter 1-2018, the Company and its subsidiaries
or received criteria, The size of the transaction is equal to 1.31 percent which is calculated by the financial statement as of June 30, 2019. Regarding, the accumulated transaction size over 6 month
criteria, The size of the transaction is equal to 1.31 percent which is calculated by the financial statement as of June 30, 2019. Regarding, the accumulated transaction size over 6 month in this criteria is
debt to equity ratio 0.35 times, shown that its sufficient liquidity and strong financial position. Please be informed accordingly, Yours Sincerely, DOD Biotech Public Company Limited (Miss Suwarin
71.15% TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 2,323.72 100.00% 2,271.46 100.00% 6 2. Financial Status 2.1 Assets As for the assets value as at 30th Sept 2017 and 31st Mar 2017, the Company and its